|
BE773113A
(fr)
*
|
1970-09-28 |
1972-01-17 |
Controlled Medications |
Composition pharmaceutique a liberation progressive de la substance active
|
|
US3909444A
(en)
*
|
1971-08-05 |
1975-09-30 |
Ncr Co |
Microcapsule
|
|
GB1456365A
(en)
*
|
1972-10-06 |
1976-11-24 |
Gist Brocades Nv |
Controlled release composition
|
|
DE2520978C3
(de)
*
|
1975-05-10 |
1981-02-19 |
Hoechst Ag, 6000 Frankfurt |
Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
|
|
DE3013839A1
(de)
*
|
1979-04-13 |
1980-10-30 |
Freunt Ind Co Ltd |
Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
|
|
US4264573A
(en)
*
|
1979-05-21 |
1981-04-28 |
Rowell Laboratories, Inc. |
Pharmaceutical formulation for slow release via controlled surface erosion
|
|
IN151913B
(enrdf_load_stackoverflow)
*
|
1980-01-11 |
1983-09-03 |
Boots Co Ltd |
|
|
US4308251A
(en)
*
|
1980-01-11 |
1981-12-29 |
Boots Pharmaceuticals, Inc. |
Controlled release formulations of orally-active medicaments
|
|
US4704284A
(en)
*
|
1982-08-12 |
1987-11-03 |
Pfizer Inc. |
Long-acting matrix tablet formulations
|
|
US4461759A
(en)
*
|
1983-01-03 |
1984-07-24 |
Verex Laboratories, Inc. |
Constant release rate solid oral dosage formulations of veropamil
|
|
US4521401A
(en)
*
|
1983-01-03 |
1985-06-04 |
Verex Laboratories, Inc. |
Constant release rate solid oral dosage formulations of quinidine
|
|
US4522804A
(en)
*
|
1983-01-03 |
1985-06-11 |
Verex Laboratories, Inc. |
Constant release rate solid oral dosage formulations of propranolol
|
|
US4882167A
(en)
*
|
1983-05-31 |
1989-11-21 |
Jang Choong Gook |
Dry direct compression compositions for controlled release dosage forms
|
|
AU581177B2
(en)
*
|
1983-05-31 |
1989-02-16 |
Choong-Gook Jang |
Dry direct compression compositions for controlled release dosage forms
|
|
US4904478A
(en)
*
|
1983-08-11 |
1990-02-27 |
Mission Pharmacal Company |
Slow-release sodium fluoride tablet and method for treatment of osteoporosis
|
|
US4726952A
(en)
*
|
1983-08-11 |
1988-02-23 |
Mission Pharmacal |
Slow-release sodium fluoride tablet, method of making, and method of treatment of osteoporosis
|
|
US4590062A
(en)
*
|
1984-04-16 |
1986-05-20 |
Tech Trade Corp. |
Dry direct compression compositions for controlled release dosage forms
|
|
DE3524003A1
(de)
|
1985-07-04 |
1987-01-08 |
Heumann Ludwig & Co Gmbh |
Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
|
|
US4608248A
(en)
*
|
1985-11-08 |
1986-08-26 |
Warner-Lambert Company |
Process for time-controlled release of active ingredients
|
|
US4837032A
(en)
*
|
1986-02-04 |
1989-06-06 |
Farval Ag |
Theophylline sustained release tablet
|
|
US4820523A
(en)
*
|
1986-04-15 |
1989-04-11 |
Warner-Lambert Company |
Pharmaceutical composition
|
|
US5025004A
(en)
*
|
1988-06-13 |
1991-06-18 |
Eastman Kodak Company |
Water-dispersible polymeric compositions
|
|
US4960814A
(en)
*
|
1988-06-13 |
1990-10-02 |
Eastman Kodak Company |
Water-dispersible polymeric compositions
|
|
GB0227948D0
(en)
*
|
2002-11-29 |
2003-01-08 |
Cipla Ltd |
Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines
|
|
US20070042041A1
(en)
*
|
2005-08-17 |
2007-02-22 |
Board Of Trustees Of The University Of Arkansas |
Drug-surfactant complexes for sustained release
|
|
US8309104B2
(en)
*
|
2006-03-02 |
2012-11-13 |
Watson Pharmaceuticals, Inc. |
Oral controlled release formulation for sedative and hypnotic agents
|
|
AU2018379992B2
(en)
|
2017-12-05 |
2022-07-21 |
Sunovion Pharmaceuticals Inc. |
Nonracemic mixtures and uses thereof
|
|
MX2020005517A
(es)
|
2017-12-05 |
2020-11-09 |
Sunovion Pharmaceuticals Inc |
Formas cristalinas y metodos de produccion de las mismas.
|
|
JP2022535893A
(ja)
|
2019-06-04 |
2022-08-10 |
サノビオン ファーマシューティカルズ インク |
放出調節製剤およびその使用
|